Part of the Access Doctor pain guide.
What Is Naproxen? Mechanism of Action, Drug Class & How It Works
A patient education guide to naproxen — the drug class it belongs to, how it produces its anti-inflammatory and analgesic effects, its pharmacokinetic properties, and how it differs from ibuprofen at a pharmacological level.
This is the pharmacology and patient education guide. For doses, clinical uses, contraindications, and how to get naproxen online, see: Naproxen for pain relief: doses, uses & online prescription →
▶ What is naproxen?
Naproxen is a propionic acid non-steroidal anti-inflammatory drug (NSAID). It works by non-selectively inhibiting COX-1 and COX-2 enzymes, blocking prostaglandin synthesis and thereby reducing inflammation, pain, and fever. Its key pharmacokinetic feature is a long plasma half-life of 12–17 hours, which allows twice-daily dosing and sustained anti-inflammatory effect.
Drug Class: What Type of Medicine Is Naproxen?
Naproxen belongs to two classification categories:
- Non-steroidal anti-inflammatory drug (NSAID) — the broader drug class; distinguishes it from steroidal anti-inflammatories (corticosteroids) and from non-anti-inflammatory analgesics like paracetamol
- Propionic acid derivative — the chemical subclass within NSAIDs; naproxen and ibuprofen are both propionic acid NSAIDs, which is why they share the same basic mechanism (COX inhibition) but differ in potency, half-life, and dosing frequency
Other common NSAIDs by chemical subclass: diclofenac is a phenylacetic acid derivative; aspirin is a salicylate; celecoxib (COX-2 selective) is a sulfonamide. All inhibit prostaglandin synthesis but via different binding characteristics and with different COX-1/COX-2 selectivity profiles.
The Mechanism of Action: COX Inhibition
To understand how naproxen works, you need to understand what prostaglandins do — because reducing their production is exactly what naproxen does.
When tissue is injured, infected, or diseased, the body activates the arachidonic acid cascade. This pathway produces prostaglandins — lipid signalling molecules that:
- Sensitise peripheral pain receptors (nociceptors), lowering their threshold and amplifying pain signals
- Cause vasodilation and increased vascular permeability — producing the redness and swelling of inflammation
- Act on the hypothalamus to raise body temperature (fever)
- Protect the gastric mucosa by stimulating mucus secretion (an important consideration for NSAID safety)
The production of prostaglandins is catalysed by two enzymes: cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). Naproxen inhibits both enzymes — blocking the biosynthetic pathway and significantly reducing prostaglandin levels throughout the body.
The result: sensitised pain receptors become less sensitised, the inflammatory cascade is dampened, and fever reduces. Naproxen is not simply masking pain — it is reducing the biological processes that cause it.
COX-1 vs COX-2: Why It Matters
| Enzyme | Location | Primary function | NSAID side effect when inhibited |
|---|---|---|---|
| COX-1 | Constitutive (always present) — stomach, kidneys, platelets | Gastric mucosal protection; renal blood flow regulation; platelet aggregation | GI irritation/ulceration; reduced platelet aggregation; renal impairment in at-risk patients |
| COX-2 | Inducible (upregulated by inflammation) — inflammatory sites | Prostaglandin production at sites of injury and inflammation | Blocking this is the therapeutic goal — but selective COX-2 inhibitors carry increased cardiovascular risk |
Naproxen inhibits both COX-1 and COX-2 non-selectively. This non-selectivity is why it produces both the desired anti-inflammatory effect (COX-2 inhibition) and the gastrointestinal side effects (COX-1 inhibition in the stomach lining). This is also why a PPI is co-prescribed with naproxen — to compensate for the reduction in COX-1-mediated gastric protection.
Pharmacokinetics: What Makes Naproxen Different from Ibuprofen
Naproxen and ibuprofen are both propionic acid NSAIDs with the same basic mechanism, but their pharmacokinetic profiles are meaningfully different:
| Property | Naproxen | Ibuprofen |
|---|---|---|
| Plasma half-life | 12–17 hours | ~2 hours |
| Dosing frequency | Twice daily | Three times daily |
| Onset of action | ~1 hour (full anti-inflammatory effect builds over days with regular dosing) | 20–30 minutes |
| Protein binding | >99% (extensive) | ~99% |
| Metabolism | Hepatic (CYP2C9); inactive metabolites excreted renally | Hepatic (CYP2C9); renally excreted |
| Cardiovascular risk profile | Considered relatively favourable among NSAIDs (some evidence of lower CV risk than other NSAIDs at equivalent doses) | Variable; dose-dependent cardiovascular risk |
The long half-life of naproxen is clinically significant. Twice-daily dosing maintains consistent anti-inflammatory plasma levels — which is particularly valuable for conditions requiring sustained anti-inflammatory effect, such as arthritis or gout.
Naproxen vs Ibuprofen: A Pharmacological Comparison
Both are propionic acid NSAIDs, both non-selectively inhibit COX-1 and COX-2, and both are effective for inflammatory pain. The pharmacological differences that have clinical implications are:
- Duration: naproxen’s 12–17 hour half-life allows twice-daily dosing; ibuprofen’s 2-hour half-life requires three-times-daily dosing to maintain anti-inflammatory levels
- Onset: ibuprofen acts faster (20–30 minutes); naproxen takes around an hour but provides more sustained relief per dose
- Gout: naproxen is NICE first-line for acute gout; ibuprofen is an alternative
- Cardiovascular: naproxen is generally considered to have a more favourable cardiovascular risk profile among non-selective NSAIDs
Naproxen vs Paracetamol: Why Mechanism Matters
Paracetamol and naproxen are both analgesics, but they work by entirely different mechanisms — and this difference is clinically important when choosing between them.
Paracetamol acts centrally, modulating pain perception in the brain and spinal cord. It does not meaningfully inhibit peripheral prostaglandin synthesis and so does not reduce inflammation at the site of injury. If your pain comes from a sprained ankle, inflamed joint, or gout attack — where prostaglandins are actively causing swelling and sensitising local pain receptors — paracetamol addresses the symptom (the pain signal reaching the brain) but not the cause (the prostaglandins producing it).
Naproxen addresses the cause. For inflammatory pain, this mechanistic difference translates directly into better clinical outcomes.
Crucially, paracetamol and naproxen are safe to take together — they work on different pathways and their combination often provides better pain relief than either alone.
Ready to Get Naproxen Prescribed Online?
Access Doctor provides prescription naproxen following a short online clinical consultation. GPhC-registered pharmacist independent prescribers. Discreet next-day delivery. GPhC pharmacy #9011198.
View Naproxen Prescribing Options →Frequently Asked Questions
What type of drug is naproxen?
Naproxen is a propionic acid non-steroidal anti-inflammatory drug (NSAID). It is in the same chemical subclass as ibuprofen but has a much longer plasma half-life (12–17 hours vs ~2 hours), allowing twice-daily rather than three-times-daily dosing.
How does naproxen work?
Naproxen non-selectively inhibits COX-1 and COX-2 enzymes, blocking prostaglandin synthesis. Prostaglandins sensitise pain receptors, mediate inflammation, and produce fever. By reducing their production, naproxen directly reduces pain, swelling, and heat at the site of inflammation.
What is the difference between COX-1 and COX-2 inhibition?
COX-1 is constitutively expressed and protects the gastric mucosa and regulates platelet function; COX-2 is upregulated at inflammatory sites and drives prostaglandin-mediated pain and inflammation. NSAIDs like naproxen inhibit both, producing anti-inflammatory benefit (COX-2) and GI side effects (COX-1). This is why a PPI is co-prescribed.
How does naproxen differ from ibuprofen pharmacologically?
Both are propionic acid NSAIDs with the same COX-inhibiting mechanism. Naproxen’s half-life is 12–17 hours, enabling twice-daily dosing and more sustained anti-inflammatory levels. Ibuprofen’s half-life is ~2 hours, requiring three-times-daily dosing for sustained effect. Naproxen is also considered by many clinicians to have a more favourable cardiovascular risk profile.
Why does naproxen work better than paracetamol for inflammatory pain?
Paracetamol acts centrally and does not significantly reduce peripheral prostaglandin synthesis — it modulates the brain’s perception of pain but does not address the inflammatory process itself. Naproxen acts at the site of inflammation, reducing the prostaglandins that sensitise pain receptors and cause swelling. For inflammatory conditions, this difference is clinically significant.
Can I take naproxen and paracetamol together?
Yes — they work by different mechanisms and can be safely combined. The combination often provides better pain relief than either alone. Never combine naproxen with ibuprofen or another NSAID.
References
- NICE CKS. NSAIDs — prescribing issues. Updated 2023.
- BNF. Naproxen. bnf.nice.org.uk
- NHS. Naproxen. nhs.uk/medicines/naproxen
- Derry S et al. Naproxen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database. 2012.
Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting or changing any treatment. In a medical emergency, call 999.